<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001946240</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0000861838</issuerCik>
      <issuerName>Aceragen, Inc.</issuerName>
      <secFileNumber>001-31918</secFileNumber>
      <issuerAddress>
        <com:street1>505 EAGLEVIEW BOULEVARD</com:street1>
        <com:street2>SUITE 212</com:street2>
        <com:city>EXTON</com:city>
        <com:stateOrCountry>PA</com:stateOrCountry>
        <com:zipCode>19341</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>4843481600</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Chopra Atul</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Wells Fargo Advisors</name>
        <address>
          <com:street1>1 N. Jefferson Ave</com:street1>
          <com:city>St. Louis</com:city>
          <com:stateOrCountry>MO</com:stateOrCountry>
          <com:zipCode>63103</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>32436</noOfUnitsSold>
      <aggregateMarketValue>44994.78</aggregateMarketValue>
      <noOfUnitsOutstanding>8423504</noOfUnitsOutstanding>
      <approxSaleDate>05/16/2023</approxSaleDate>
      <securitiesExchangeName>Nasdaq</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>09/28/2022</acquiredDate>
      <natureOfAcquisitionTransaction>Series Z Share Conversion</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>32436</amountOfSecuritiesAcquired>
      <paymentDate>09/28/2022</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Atul Chopra</name>
        <address>
          <com:street1>505 Eagleview Blvd</com:street1>
          <com:street2>Suite 212</com:street2>
          <com:city>Exton</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19341</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Aceragen, Inc.</securitiesClassTitle>
      <saleDate>05/12/2023</saleDate>
      <amountOfSecuritiesSold>81486</amountOfSecuritiesSold>
      <grossProceeds>125188.24</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Atul Chopra</name>
        <address>
          <com:street1>505 Eagleview Blvd</com:street1>
          <com:street2>Suite 212</com:street2>
          <com:city>Exton</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19341</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Aceragen, Inc.</securitiesClassTitle>
      <saleDate>05/11/2023</saleDate>
      <amountOfSecuritiesSold>47166</amountOfSecuritiesSold>
      <grossProceeds>86419.97</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Atul Chopra</name>
        <address>
          <com:street1>505 Eagleview Blvd.</com:street1>
          <com:street2>Suite 212</com:street2>
          <com:city>Exton</com:city>
          <com:stateOrCountry>PA</com:stateOrCountry>
          <com:zipCode>19341</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Aceragen, Inc.</securitiesClassTitle>
      <saleDate>05/15/2023</saleDate>
      <amountOfSecuritiesSold>74927</amountOfSecuritiesSold>
      <grossProceeds>109472.13</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>05/16/2023</noticeDate>
      <signature>Atul Chopra</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
[{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4638}]
144
0001946240
XXXXXXXX
LIVE
0000861838
Aceragen, Inc.
001-31918
505 EAGLEVIEW BOULEVARD
SUITE 212
EXTON
PA
19341
4843481600
Chopra Atul
10% Stockholder
Common
Wells Fargo Advisors
1 N. Jefferson Ave
St. Louis
MO
63103
32436
44994.78
8423504
05/16/2023
Nasdaq
Common
09/28/2022
Series Z Share Conversion
Issuer
N
32436
09/28/2022
N/A
N
Atul Chopra
505 Eagleview Blvd
Suite 212
Exton
PA
19341
Aceragen, Inc.
05/12/2023
81486
125188.24
Atul Chopra
505 Eagleview Blvd
Suite 212
Exton
PA
19341
Aceragen, Inc.
05/11/2023
47166
86419.97
Atul Chopra
505 Eagleview Blvd.
Suite 212
Exton
PA
19341
Aceragen, Inc.
05/15/2023
74927
109472.13
05/16/2023
Atul Chopra